A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections

NCT01110408 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

41

Enrollment

INDUSTRY

Sponsor class

Stopped Trial terminated early per business decision

Conditions

Complicated Urinary Tract Infections or Pyelonephritis

Interventions

DRUG: Doripenem
DRUG: Doripenem placebo
DRUG: Cefepime
DRUG: Cefepime placebo
DRUG: Amoxicillin/clavulanate potassium

Sponsor

Janssen Research & Development, LLC